Qualigen Therapeutics, Inc.

NASDAQ (USD): Qualigen Therapeutics, Inc. (QLGN)

Last Price

0.27

Today's Change

-0.01 (3.57%)

Day's Change

0.235 - 0.288

Trading Volume

4,423,359

Overview

Market Cap

2 Million

Shares Outstanding

9 Million

Avg Volume

5,410,252

Avg Price (50 Days)

0.25

Avg Price (200 Days)

0.52

PE Ratio

-0.11

EPS

-2.46

Earnings Announcement

13-Aug-2024

Previous Close

0.28

Open

0.24

Day's Range

0.2354 - 0.288

Year Range

0.145 - 1.26

Trading Volume

4,424,306

Price Change Highlight

1 Day Change

-3.92%

5 Day Change

64.93%

1 Month Change

34.50%

3 Month Change

-29.49%

6 Month Change

-47.15%

Ytd Change

-51.44%

1 Year Change

-70.60%

3 Year Change

-98.60%

5 Year Change

-99.90%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment